New treatments for macular degeneration
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
Strategy
Truffle Capital launches new technology funds
Interviewee/Contributor
Philippe Pouletty
Organisation
Truffle Capital
Ion channel drug discovery and modern medicine
Interviewee/Contributor
Marc Rogers
Organisation
Metrion Biosciences Ltd
Human gene therapy - immunogenicity perspective
Interviewee/Contributor
J Fraser Wright
Organisation
Stanford University School of Medicine
Galapagos shows that the fittest can survive
Interviewee/Contributor
Piet Wigerinck and Walid Abi-Saab
Organisation
Galapagos NV
Exploiting enzymes from the Arctic Ocean
Interviewee/Contributor
Christian Jørgensen
Organisation
Biotec Pharmacon ASA
Technology for direct cell reprogramming
Interviewee/Contributor
Julian Gough
Organisation
Mogrify Ltd
Vivoryon Therapeutics tests Alzheimer's drug
Interviewee/Contributor
Ulrich Dauer
Organisation
Vivoryon Therapeutics AG
Taking on the Alzheimer's conundrum
Interviewee/Contributor
Reisa Sperling
Organisation
Harvard Medical School
Revisiting antibody-drug conjugates
Interviewee/Contributor
Chris Martin
Organisation
ADC Therapeutics SA